IL6 and synovial sarcoma: Other data obtained after analyzing a cohort of 68 SS patients support the prognostic value of IL-6, with increased values being correlated with the extension of skin involvement at the 3-year follow-up, the development of pulmonary fibrosis, and worse long-term survival.